Observational Study of Chinese Patients with End Stage Renal Disease Receiving Hemodialysis Tracking Survival, Quality of Life, and Access Patency Over 10 Years

What this Trial Is About

Researchers are enrolling patients with end stage renal disease ESRD who are receiving hemodialysis HD treatment to create a comprehensive HD database in China. This observational study aims to collect and compare patient survival, technical survival, access patency rates, quality of life, and residual kidney function among HD patients. The study is led by Sun Yat-sen University and includes patients treated at multiple hospitals. Participants have their demographic details, clinical characteristics, complications, medications, and quality of life measured at the start and then every 3 months during follow-up visits. Information recorded includes blood pressure, causes of ESRD, lab tests, and treatment outcomes such as mortality, kidney transplantation, access failure, hospitalizations, and transfer to other dialysis methods. During the study, patients are regularly assessed every three months with updates entered into the registration system. Researchers use this data to evaluate key outcomes like patient survival over 10 years, quality of life using the SF36 scale, and access patency rates. This ongoing follow-up helps provide detailed insights into the experiences and health of HD patients over time.

Wise Practice of Chinese Hemodialysis (WISHES)